Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

2.

Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.

Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H, Kronenberg F.

J Am Soc Nephrol. 1997 Dec;8(12):1889-98.

3.
4.

Relationship between serum albumin level before initiating haemodialysis and angiographic severity of coronary atherosclerosis in end-stage renal disease patients.

Joki N, Hase H, Tanaka Y, Takahashi Y, Saijyo T, Ishikawa H, Inishi Y, Imamura Y, Hara H, Tsunoda T, Nakamura M.

Nephrol Dial Transplant. 2006 Jun;21(6):1633-9. Epub 2006 Feb 17.

PMID:
16488920
5.
6.

Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease.

Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG.

J Am Soc Nephrol. 2003 Feb;14(2):415-24.

7.

Clinical correlates of hypertensive end-stage renal disease.

Bleyer AJ, Chen R, D'Agostino RB Jr, Appel RG.

Am J Kidney Dis. 1998 Jan;31(1):28-34.

PMID:
9428448
8.

Cardiovascular disease risk factors in chronic renal insufficiency.

Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ, Levey AS.

Clin Nephrol. 2002 May;57(5):327-35.

PMID:
12036190
9.

Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy.

Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B.

Nephrol Dial Transplant. 1997 Jun;12(6):1187-91.

PMID:
9198049
10.

Predictors of coronary disease in patients with end stage renal disease.

Varghese K, Cherian G, Abraham UT, Hayat NJ, Johny KV.

Ren Fail. 2001 Nov;23(6):797-806.

PMID:
11777319
11.

Determinants and prognostic importance of cardiomegaly among new ESRD patients in the United States.

Stack AG, Serna H, Ramsanahie A, Henry C.

Ann Epidemiol. 2004 Oct;14(9):676-85.

PMID:
15380799
12.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease.

McCullough PA.

Kidney Int Suppl. 2005 Jun;(95):S51-8. Review.

PMID:
15882314
13.

Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States.

Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ.

J Am Soc Nephrol. 1999 Aug;10(8):1793-800.

14.

Predialysis management and predictors for early mortality in uremic patients who die within one year after initiation of dialysis therapy.

Biesenbach G, Hubmann R, Janko O, Schmekal B, Eichbauer-Sturm G.

Ren Fail. 2002 Mar;24(2):197-205.

PMID:
12071593
15.

[Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].

Portolés J, López-Gómez JM, Aljama P.

Nefrologia. 2005;25(3):297-306. Spanish.

16.

Screening for significant coronary artery disease in high-risk renal transplant candidates.

Gowdak LH, de Paula FJ, César LA, Martinez Filho EE, Ianhez LE, Krieger EM, Ramires JA, de Lima JJ.

Coron Artery Dis. 2007 Nov;18(7):553-8.

PMID:
17925609
17.

Malnutrition inflammation score is associated with coronary artery disease in hepatitis C virus-infected hemodialysis patients.

Elsurer R, Afsar B, Sezer S, Arat Z, Ozdemir FN, Haberal M.

Eur J Clin Nutr. 2008 Dec;62(12):1449-54. Epub 2007 Aug 1.

PMID:
17671439
18.

Coronary artery disease as a definitive risk factor of short-term outcome after starting hemodialysis in diabetic renal failure patients.

Joki N, Hase H, Ishikawa H, Fukazawa C, Nakamura R, Imamura Y, Tanaka Y, Saijyo T, Fukazawa M, Yamaguchi T.

Clin Nephrol. 2001 Feb;55(2):109-14.

PMID:
11269673
19.

An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.

Stompór T, Pasowicz M, Sulłowicz W, Dembińska-Kieć A, Janda K, Wójcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E.

Am J Kidney Dis. 2003 Jan;41(1):203-11.

PMID:
12500238
20.

Prevalence and predictors of significant coronary artery disease in Turkish patients who undergo heart valve surgery.

Sonmez K, Gencbay M, Akcay A, Yilmaz A, Pala S, Onat O, Duran NE, Degertekin M, Turan F.

J Heart Valve Dis. 2002 May;11(3):431-7.

PMID:
12056739

Supplemental Content

Support Center